FDA Staff Flag Renal Risk of Diabetes Drug
(MedPage Today) -- The novel type 2 diabetes drug canagliflozin (Invocana) is effective at lowering blood glucose, but FDA reviewers have raised concerns about renal and fracture risks.
Tags:
FDA Staff Flag Renal Risk of Diabetes Drug,
Diabetes Latest News